Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2.SummaryDifference0.1%
- Check55 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 5 locations, replacing the previous version v2.9.7.SummaryDifference0.4%
- Check62 days agoChange DetectedThe website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.SummaryDifference0.1%
- Check76 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check81 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.